Form 8-K - Current report:
SEC Accession No. 0001564590-22-014472
Filing Date
2022-04-14
Accepted
2022-04-14 16:25:35
Documents
14
Period of Report
2022-04-14
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K txmd-8k_20220414.htm   iXBRL 8-K 34498
2 EX-99.1 txmd-ex991_7.htm EX-99.1 15343
3 GRAPHIC gaqusqvpr52u000001.jpg GRAPHIC 6973
  Complete submission text file 0001564590-22-014472.txt   193192

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA txmd-20220414.xsd EX-101.SCH 5717
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE txmd-20220414_lab.xml EX-101.LAB 19426
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE txmd-20220414_pre.xml EX-101.PRE 11604
8 EXTRACTED XBRL INSTANCE DOCUMENT txmd-8k_20220414_htm.xml XML 3549
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-00100 | Film No.: 22827598
SIC: 2834 Pharmaceutical Preparations